直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Federal Circuit Clarifies Reach of Patent Estoppel in SoftView v. Apple

August 8, 2024

Authored and Edited by Christina Ji-Hye Yang; Sonja W. Sahlsten; Prince M. Ene, Pharm. D.

In SoftView LLC v. Apple Inc., No. 23-1005, (Fed. Cir. July 26, 2024), the Federal Circuit partially vacated and remanded the PTAB’s decision finding certain claims of U.S. Patent No. 7,461,353 (’353 patent) unpatentable.

After the PTAB found 18 of the 319 claims of the ’353 patent unpatentable in an IPR, SoftView sought to amend 107 of the ’353 patent claims in an ex parte reexamination, which the PTO found unpatentable. On appeal, the Board reversed the Examiner’s obviousness rejection but entered a new ground of rejection, finding that each amended claim is essentially the same as a canceled claim or merely a combination of limitations that had previously invalidated. SoftView appealed, arguing that the Board misapplied the estoppel provision in 37 C.F.R. § 42.73(d)(3)(i) and that the PTO lacked authority to promulgate it.

The Federal Circuit affirmed the PTO’s statutory authority to promulgate § 42.73(d)(3)(i), which falls within the PTO’s authority to issue regulations to ensure the integrity of the trial procedures. The Federal Circuit further held that § 42.73(d)(3)(i) goes beyond the common law estoppel by calling for a comparison between the claims an applicant is obtaining and the finally refused or cancelled claim. It then vacated the Board’s decision as to the issued claims on appeal but affirmed as to the amended claims because the regulation applies to “obtaining” a claim, not maintaining an existing claim.

Tags

estoppel, validity, Patent Trial and Appeal Board (PTAB)

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Industries

AI, Electronics, and Information Technology

Electrical and Computer Technology

Related Offices

Washington, DC

Contacts

Christina Ji-Hye Yang
Partner
Washington, DC
+1 202 408 4465
Email
Sonja W. Sahlsten
Partner
Washington, DC
+1 202 408 4329
Email
Prince M. Ene, Pharm. D.
Associate
Washington, DC
+1 202 408 4036
Email

Copyright © 2024 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP